Newbridge Financial Services Group, Inc. Beam Therapeutics Inc. Transaction History
Newbridge Financial Services Group, Inc.
- $575 Million
- Q2 2025
A detailed history of Newbridge Financial Services Group, Inc. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 200 shares of BEAM stock, worth $5,346. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 200
-0.0%
Holding current value
$5,346
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BEAM
# of Institutions
246Shares Held
95.8MCall Options Held
666KPut Options Held
1.99M-
Farallon Capital Management LLC San Francisco, CA10MShares$268 Million0.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.71MShares$259 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.85MShares$237 Million1.24% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$204 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.4.83MShares$129 Million0.07% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.88B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...